Showing 2,261 - 2,280 results of 18,045 for search 'significantly ((((((less decrease) OR (largest decrease))) OR (teer decrease))) OR (a decrease))', query time: 0.71s Refine Results
  1. 2261

    Principal coordinates analysis (PCoA). by Wararak Choovanichvong (22110371)

    Published 2025
    “…Analysis of bacterial abundance revealed a shift in trends as the disease combined from control to NSESKD and SESKD group, respectively, across 7 genera: <i><i>Actinobacillus</i></i>, <i>TM7x</i>, <i><i>Capnocytophaga</i></i>, <i><i>Neisseria</i></i>, and <i><i>Leptotrichia</i></i> increased in abundance, while <i><i>Actinomyces</i></i> and <i><i>Atopobium</i></i> decreased. …”
  2. 2262

    Initial participants by wave*. by Yeo Ju Sohn (18536198)

    Published 2024
    “…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”
  3. 2263

    General characteristics of research participants. by Yeo Ju Sohn (18536198)

    Published 2024
    “…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”
  4. 2264
  5. 2265

    Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  6. 2266

    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  7. 2267
  8. 2268
  9. 2269
  10. 2270
  11. 2271
  12. 2272
  13. 2273

    Data. by Aroon La-up (14095691)

    Published 2025
    “…This study found a statistically significant decrease in BMD in the group with the lowest U-Cd levels (<2.0 μg/g creatinine, p = 0.001) and in the overall sample (from 0.392 ± 0.079 μg/g creatinine in 2019 to 0.384 ± 0.094 μg/g creatinine in 2022, p = 0.004). …”
  14. 2274
  15. 2275
  16. 2276
  17. 2277
  18. 2278
  19. 2279
  20. 2280